NEXIEN BIOPHARMA, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Nexien Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2013 to Q3 2024.
  • Nexien Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$32K, a 57.3% increase year-over-year.
  • Nexien Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$196K, a 42.6% increase year-over-year.
  • Nexien Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$239K, a 33.9% increase from 2023.
  • Nexien Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$362K, a 42.2% increase from 2022.
  • Nexien Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$626K, a 66.3% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$196K -$32K +$42.9K +57.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-18
Q2 2024 -$239K -$86.5K +$7.07K +7.55% Apr 1, 2024 Jun 30, 2024 10-K 2024-10-22
Q1 2024 -$246K -$53.2K +$26.7K +33.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$273K -$24.5K +$69.1K +73.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$342K -$74.9K +$20K +21% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-18
Q2 2023 -$362K -$93.6K +$3.42K +3.52% Apr 1, 2023 Jun 30, 2023 10-K 2024-10-22
Q1 2023 -$365K -$79.9K +$108K +57.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$473K -$93.6K +$127K +57.5% Oct 1, 2022 Dec 31, 2022 10-Q 2024-05-15
Q3 2022 -$600K -$94.9K +$26.8K +22.1% Jul 1, 2022 Sep 30, 2022 10-Q 2024-05-15
Q2 2022 -$626K -$97K +$84.7K +46.6% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-28
Q1 2022 -$711K -$187K -$399K -189% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-17
Q4 2021 -$312K -$220K +$608K +73.4% Oct 1, 2021 Dec 31, 2021 10-Q 2023-05-17
Q3 2021 -$920K -$122K +$940K +88.5% Jul 1, 2021 Sep 30, 2021 10-Q 2023-05-17
Q2 2021 -$1.86M -$182K +$492K +73% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-28
Q1 2021 -$2.35M $211K +$771K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$3.12M -$828K -$132K -18.9% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-08
Q3 2020 -$2.99M -$1.06M -$320K -43.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$2.67M -$674K +$386K +36.4% Apr 1, 2020 Jun 30, 2020 10-K 2021-10-12
Q1 2020 -$3.06M -$560K -$74.9K -15.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$2.98M -$696K +$1.26M +64.5% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 -$4.25M -$742K +$55.7K +6.98% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$4.3M -$1.06M -$798K -306% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-28
Q1 2019 -$3.5M -$485K -$217K -81.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$3.29M -$1.96M -$1.66M -546% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-12
Q3 2018 -$1.63M -$798K -$346K -76.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$1.28M -$261K -$69.7K -36.4% Apr 1, 2018 Jun 30, 2018 10-K 2019-09-30
Q1 2018 -$1.21M -$268K -$201K -298% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$1.01M -$303K -$298K -6231% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$715K -$451K -$444K -6629% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$270K -$191K -$187K -3902% Mar 27, 2017 Jun 30, 2017 10-K 2018-09-28
Q1 2017 -$83.5K -$67.2K -$62K -1182% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$21.5K -$4.79K -$313 -6.99% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-06
Q3 2016 -$21.2K -$6.7K -$219 -3.38% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$21K -$4.78K -$550 -13% Apr 1, 2016 Jun 30, 2016 10-K 2017-07-31
Q1 2016 -$20.4K -$5.24K -$1.38K -35.6% Jan 1, 2016 Mar 31, 2016 10-Q 2016-04-13
Q4 2015 -$19.1K -$4.48K +$35.9K +88.9% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-06
Q3 2015 -$54.9K -$6.48K -$6.48K Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-19
Q2 2015 -$48.4K -$4.23K Apr 1, 2015 Jun 30, 2015 10-K 2016-09-28
Q1 2015 -$3.87K -$3.4K -721% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-13
Q4 2014 -$40.3K -$40.3K Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-04
Q3 2014 -$9* Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-14
Q1 2014 -$471 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 -$10* Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.